oramed-unstable-diabetes-drug-is-a-hit

Oramed ‘unstable diabetes’ drug is a hit

  • Rest of Asia
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Oramed Pharmaceuticals' article titled, ‘Glucose-reducing effect of the ORMD-0801 oral insulin preparation in patients with uncontrolled type 1 diabetes... Read more

german-vaccine-delivery-company-enters-china

German vaccine delivery company enters China

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: German company Injex Pharma registered Injex30 needle free injection system with the Chinese State Food and Drug Administration (SFDA). The company's... Read more

rnl-bio-filed-ind-with-the-us-fda-to-begin-clinical-trials-with-rnl-jointstem

RNL BIO files IND for stem cell product with FDA

  • Korea
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: RNL BIO, Korea-based stem cell biotechnology company, has filed an Investigational New Drug application (IND) with the US FDA to begin clinical trials... Read more

teva-pharma-to-close-its-206-000-square-feet-sellersville-facility-by-2017

Teva to shut down US site, cut many jobs

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Teva Pharmaceutical Industries decided to close its manufacturing and research facility in Sellersville, Bucks County, US, by 2017, as the net income... Read more

abide-therapeutics-entered-into-an-agreement-with-merck-msd-to-discover-develop-and-commercialize-small-molecule-therapies-for-type-2-diabetes

Merck to pay up to $430 mn to Abide for diabetes deal

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Abide Therapeutics, a biopharmaceutical company pioneering innovative approaches to selectively target a group of enzymes known as serine hydrolases,... Read more

pfizer-us-may-reach-a-final-decision-on-whether-or-not-to-split-itself-into-brand-name-and-generics-businesses-only-by-2016

Pfizer US may split its generics business

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Pfizer, US, is contemplating the thought of splitting itself into brand name and generics businesses. Mr Frank D'Amelio, chief financial officer, Pfizer,... Read more

tianyin-pharmaceutical-completed-construction-of-its-53-000-square-meters-qionglai-facility-qlf

Tianyin TCM raw material processing plant is ready

  • China
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

‎Singapore: Tianyin Pharmaceutical, a pharmaceutical company that specializes in patented biopharmaceutical, modernized traditional Chinese medicine (mTCM), branded... Read more

pharmaceutical-product-development-s-ppd-has-been-ranked-second-in-centerwatch-s-2013-global-investigative-site-relationship-survey-for-reputation-among-all-contract-research-organizations-cros

PPD ranked 2nd by CenterWatch CRO site survey

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Pharmaceutical Product Development's (PPD) site has been acknowledged by CenterWatch's 2013 Global Investigative Site Relationship Survey for reputation... Read more

bausch-lomb-to-distribute-physiol-s-finevision-trifocal-and-finevision-trifocal-toric-hydrophilic-aspheric-intraocular-lenses-iols

Bausch+Lomb to distribute PhysIOL lense in Asia

  • US
  • |
  • News
  • |
  • By BioSpectrum Bureau
  • |
  • 0 Comment

Singapore: Bausch + Lomb, the global eye health company has been appointed as distributor of several lines of intraocular lense manufacturer, PhysIOL's hydrophilic... Read more

Special Features

Survey Box

Chinese Bird Flu H5N7

Have Chinese scientists done the right thing by fusing human and avian flu strains to create new killer viruses?

Send this article by email

X